Clinical Features	Time to Death		AGE		NEOPLASM.DISEASESTAGE		PATHOLOGY.T.STAGE		PATHOLOGY.N.STAGE		GENDER		RADIATIONS.RADIATION.REGIMENINDICATION		NUMBERPACKYEARSSMOKED		NUMBER.OF.LYMPH.NODES		RACE		ETHNICITY	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	Wilcoxon-test_P	Wilcoxon-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Wilcoxon-test_P	Wilcoxon-test_Q	Wilcoxon-test_P	Wilcoxon-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q
TP53	213 (70%)	93	0.02164	1	0.50892	1	0.0093099	1	0.0055199	1	0.01605	1	0.78076	1	0.12314	1	0.063519	1	0.0077589	1	0.65103	1	0.24276	1
CDKN2A	65 (21%)	241	0.4107	1	0.40941	1	0.27146	1	0.66647	1	0.95038	1	0.63989	1	0.42848	1	0.010743	1	0.78507	1	0.77895	1	0.19742	1
CASP8	27 (9%)	279	0.51345	1	7.6111e-06	0.00225	0.31656	1	0.55843	1	0.085559	1	0.0012748	0.375	0.37202	1	0.21519	1	0.041616	1	0.41623	1	0.35142	1
FAT1	69 (23%)	237	0.57114	1	0.0014219	0.417	0.53704	1	0.44781	1	0.85327	1	0.067685	1	0.75808	1	0.34062	1	0.29506	1	0.19029	1	0.088949	1
MLL2	53 (17%)	253	0.94418	1	0.98773	1	0.36937	1	0.12342	1	0.88432	1	0.86689	1	1	1	0.52008	1	0.91888	1	0.50088	1	1	1
JUB	18 (6%)	288	0.0020911	0.609	0.15513	1	0.776	1	0.45511	1	0.29529	1	1	1	1	1	0.19566	1	0.22145	1	0.091079	1	0.57018	1
NOTCH1	57 (19%)	249	0.75847	1	0.14423	1	0.83589	1	0.75246	1	0.93529	1	0.18751	1	0.40519	1	0.064932	1	0.40315	1	0.93186	1	0.15116	1
NFE2L2	17 (6%)	289	0.56594	1	0.0093885	1	0.69537	1	0.77305	1	1	1	0.26064	1	0.25598	1	0.96513	1	0.67683	1	0.17908	1	0.52402	1
NSD1	33 (11%)	273	0.087694	1	0.086526	1	0.04137	1	0.78012	1	0.00064999	0.192	0.30097	1	0.30141	1	0.091343	1	0.0030102	0.87	0.38111	1	0.051327	1
HRAS	10 (3%)	296	0.21282	1	0.29341	1	0.1611	1	0.24042	1	0.04908	1	1	1	0.46472	1	0.21375	1	0.053365	1	0.6783	1	1	1
ZNF750	13 (4%)	293	0.36757	1	0.82374	1	0.67232	1	0.059399	1	0.74811	1	0.12301	1	0.52517	1	0.67741	1	0.35696	1	0.32662	1	1	1
RASA1	14 (5%)	292	0.96834	1	0.94205	1	0.90739	1	0.5216	1	1	1	0.36448	1	0.53444	1	0.69376	1	0.60761	1	0.53249	1	0.49925	1
HLA-A	9 (3%)	297	0.14196	1	0.30703	1	0.42133	1	0.62053	1	0.34139	1	1	1	0.70331	1	0.46259	1	0.70087	1	0.66501	1	1	1
EPHA2	13 (4%)	293	0.99857	1	0.6746	1	0.88632	1	0.94993	1	0.59923	1	0.19917	1	1	1	0.02311	1	0.43872	1	0.1143	1	0.47328	1
RAC1	9 (3%)	297	0.10199	1	0.0021257	0.616	0.37922	1	0.41049	1	0.21543	1	0.067629	1	1	1	0.70086	1	0.16349	1	1	1	1	1
EP300	24 (8%)	282	0.71276	1	0.42684	1	0.59035	1	0.92673	1	0.69565	1	0.48323	1	0.63408	1	0.41284	1	0.94983	1	0.27144	1	0.29626	1
TGFBR2	10 (3%)	296	0.69366	1	0.08129	1	0.871	1	0.71213	1	0.34089	1	0.4703	1	0.06781	1	0.12034	1	0.48496	1	0.12217	1	1	1
PIK3CA	64 (21%)	242	0.18276	1	0.79007	1	0.43445	1	0.74033	1	0.46532	1	0.11444	1	1	1	0.99561	1	0.46224	1	0.050479	1	1	1
FBXW7	15 (5%)	291	0.53597	1	0.1432	1	0.3602	1	0.6348	1	0.29419	1	0.37184	1	0.55305	1	0.21758	1	0.56782	1	0.1585	1	0.49925	1
RB1	10 (3%)	296	0.39548	1	0.72844	1	0.18116	1	0.24087	1	0.66742	1	0.14455	1	1	1	0.90508	1	0.58213	1	0.23308	1	1	1
CTCF	11 (4%)	295	0.29865	1	0.042229	1	0.63521	1	0.93415	1	0.66094	1	0.1811	1	0.4897	1	0.48908	1	0.18602	1	0.26479	1	1	1
KDM6A	8 (3%)	298	0.19982	1	0.76589	1	0.56892	1	0.457	1	0.89131	1	0.45323	1	0.686	1	0.98086	1	0.57387	1	0.075159	1	1	1
ELF4	5 (2%)	301	0.93267	1	0.71165	1	0.051209	1	0.20338	1	0.40517	1	1	1	0.33026	1	0.55267	1	0.19191	1	1	1	1	1
RHOA	4 (1%)	302	0.0064149	1	0.76511	1	0.6383	1	0.22497	1	0.40728	1	0.30318	1	0.57641	1	0.47541	1	0.95263	1	1	1	1	1
HLA-B	8 (3%)	298	0.26199	1	0.59704	1	0.29505	1	0.76568	1	0.10889	1	0.22168	1	0.1154	1	0.31078	1	0.092349	1	1	1	1	1
PRSS1	7 (2%)	299	0.87039	1	0.68444	1	0.18616	1	0.91066	1	0.092089	1	0.0020373	0.595	0.19585	1	NA	NA	0.18461	1	0.095709	1	1	1
GUCY2F	8 (3%)	298	0.16835	1	0.96607	1	0.40277	1	0.30878	1	0.67006	1	1	1	0.4404	1	0.70371	1	0.29286	1	0.12096	1	1	1